Catheter-Based Treatments for Hepatic Metastases From Neuroendocrine Tumors

被引：14
作者：
Kolbeck, Kenneth J. [1 ]
Farsad, Khashayar [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Dotter Intervent Inst, Portland, OR 97239 USA
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2014年 / 203卷 / 04期
关键词：
chemoembolization; liver metastases; neuroendocrine tumors; octreotide; radioembolization; NANETS CONSENSUS GUIDELINES; LIVER METASTASES; CARCINOID-TUMORS; Y-90; RADIOEMBOLIZATION; TREATMENT STRATEGIES; ENDOCRINE TUMORS; OCTREOTIDE LAR; MANAGEMENT; DIAGNOSIS; RESECTION;
D O I：
10.2214/AJR.14.12983
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The purpose of this article is to present our experience in treating patients with hepatic metastases from a neuroendocrine primary malignancy. CONCLUSION. The tumor and patient characteristics, vascular access, and features of treatment all play a role in the long-term management of patients with metatastic neuroendocrine tumors. Routine prophylactic measures are recommended to reduce the frequency and severity of crisis events related to hormone release in patients with neuroendocrine tumors.
引用
收藏
页码：717 / 724
页数：8
相关论文
共 71 条
  • [41] Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Oberg, K.
    Knigge, U.
    Kwekkeboom, D.
    Perren, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 124 - 130
  • [42] The Management of Neuroendocrine Tumours: Current and Future Medical Therapy Options
    Oberg, K. E.
    [J]. CLINICAL ONCOLOGY, 2012, 24 (04) : 282 - 293
  • [43] Oberndorfer S., 1907, FRANKFURT Z PATHOL, V1, P426
  • [44] Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors
    Osborne, DA
    Zervos, EE
    Strosberg, J
    Boe, BA
    Malafa, M
    Rosemurgy, AS
    Yeatman, TJ
    Carey, L
    Duhaine, L
    Kvols, LK
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (04) : 572 - 581
  • [45] Patel FB, 2013, ANTICANCER RES, V33, P4001
  • [46] Carcinoid Tumors
    Pinchot, Scott N.
    Holen, Kyle
    Sippel, Rebecca S.
    Chen, Herbert
    [J]. ONCOLOGIST, 2008, 13 (12) : 1255 - 1269
  • [47] Carcinoid: the disease and its implications for anaesthesia
    Powell, Bruce
    Al Mukhtar, Ahmed
    Mills, Gary H.
    [J]. BJA EDUCATION, 2011, 11 (01) : 9 - 13
  • [48] Established and potential therapeutic applications of octreotide in palliative care
    Prommer, Eric E.
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (10) : 1117 - 1123
  • [49] Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
    Ramage, John K.
    Ahmed, A.
    Ardill, J.
    Bax, N.
    Breen, D. J.
    Caplin, M. E.
    Corrie, P.
    Davar, J.
    Davies, A. H.
    Lewington, V.
    Meyer, T.
    Newell-Price, J.
    Poston, G.
    Reed, N.
    Rockall, A.
    Steward, W.
    Thakker, R. V.
    Toubanakis, C.
    Valle, J.
    Verbeke, C.
    Grossman, A. B.
    [J]. GUT, 2012, 61 (01) : 6 - 32
  • [50] Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
    Raymond, Eric
    Dahan, Laetitia
    Raoul, Jean-Luc
    Bang, Yung-Jue
    Borbath, Ivan
    Lombard-Bohas, Catherine
    Valle, Juan
    Metrakos, Peter
    Smith, Denis
    Vinik, Aaron
    Chen, Jen-Shi
    Hoersch, Dieter
    Hammel, Pascal
    Wiedenmann, Bertram
    Van Cutsem, Eric
    Patyna, Shem
    Lu, Dongrui Ray
    Blanckmeister, Carolyn
    Chao, Richard
    Ruszniewski, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06) : 501 - 513
12345678